chr2-151870575-T-C

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 1P and 12B. PVS1_SupportingBP6_Very_StrongBS2

The NM_001330114.2(CACNB4):​c.1A>G​(p.Met1?) variant causes a start lost change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000455 in 1,613,932 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0024 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00025 ( 0 hom. )

Consequence

CACNB4
NM_001330114.2 start_lost

Scores

6
8
4

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 7.99

Publications

8 publications found
Variant links:
Genes affected
CACNB4 (HGNC:1404): (calcium voltage-gated channel auxiliary subunit beta 4) This gene encodes a member of the beta subunit family of voltage-dependent calcium channel complex proteins. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. Various versions of each of these subunits exist, either expressed from similar genes or the result of alternative splicing. The protein encoded by this locus plays an important role in calcium channel function by modulating G protein inhibition, increasing peak calcium current, controlling the alpha-1 subunit membrane targeting and shifting the voltage dependence of activation and inactivation. Certain mutations in this gene have been associated with idiopathic generalized epilepsy (IGE), juvenile myoclonic epilepsy (JME), and episodic ataxia, type 5. [provided by RefSeq, Aug 2016]
CACNB4 Gene-Disease associations (from GenCC):
  • episodic ataxia type 5
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • juvenile myoclonic epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, idiopathic generalized, susceptibility to, 9
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • epilepsy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

PVS1
Start lost variant, no pathogenic variants between lost start and next in-frame start position. Next in-frame start position is after 19 codons. Genomic position: 151869226. Lost 0.061 part of the original CDS.
BP6
Variant 2-151870575-T-C is Benign according to our data. Variant chr2-151870575-T-C is described in ClinVar as Benign. ClinVar VariationId is 136652.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 370 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001330114.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNB4
NM_000726.5
MANE Select
c.655A>Gp.Met219Val
missense
Exon 8 of 14NP_000717.2O00305-1
CACNB4
NM_001330114.2
c.1A>Gp.Met1?
start_lost
Exon 7 of 13NP_001317043.1
CACNB4
NM_001005746.4
c.601A>Gp.Met201Val
missense
Exon 8 of 14NP_001005746.1O00305-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNB4
ENST00000539935.7
TSL:1 MANE Select
c.655A>Gp.Met219Val
missense
Exon 8 of 14ENSP00000438949.1O00305-1
CACNB4
ENST00000534999.7
TSL:1
c.553A>Gp.Met185Val
missense
Exon 7 of 13ENSP00000443893.1O00305-2
CACNB4
ENST00000201943.10
TSL:1
c.655A>Gp.Met219Val
missense
Exon 8 of 13ENSP00000201943.5O00305-4

Frequencies

GnomAD3 genomes
AF:
0.00243
AC:
370
AN:
152186
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00835
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00105
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.000506
AC:
126
AN:
249062
AF XY:
0.000414
show subpopulations
Gnomad AFR exome
AF:
0.00698
Gnomad AMR exome
AF:
0.000377
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000354
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000250
AC:
365
AN:
1461628
Hom.:
0
Cov.:
30
AF XY:
0.000202
AC XY:
147
AN XY:
727088
show subpopulations
African (AFR)
AF:
0.00828
AC:
277
AN:
33470
American (AMR)
AF:
0.000537
AC:
24
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000812
AC:
7
AN:
86238
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53394
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000279
AC:
31
AN:
1111832
Other (OTH)
AF:
0.000398
AC:
24
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
19
38
56
75
94
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00243
AC:
370
AN:
152304
Hom.:
2
Cov.:
33
AF XY:
0.00240
AC XY:
179
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.00832
AC:
346
AN:
41570
American (AMR)
AF:
0.00105
AC:
16
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68028
Other (OTH)
AF:
0.00189
AC:
4
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
20
40
60
80
100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000745
Hom.:
1
Bravo
AF:
0.00285
ESP6500AA
AF:
0.00547
AC:
23
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000628
AC:
76
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (4)
-
-
1
CACNB4-related disorder (1)
-
-
1
Idiopathic generalized epilepsy (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.54
BayesDel_addAF
Benign
-0.061
T
BayesDel_noAF
Pathogenic
0.15
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Benign
0.30
T
Eigen
Pathogenic
0.78
Eigen_PC
Pathogenic
0.78
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
0.97
D
M_CAP
Uncertain
0.091
D
MetaRNN
Benign
0.017
T
MetaSVM
Uncertain
0.33
D
MutationAssessor
Uncertain
2.1
M
PhyloP100
8.0
PrimateAI
Uncertain
0.72
T
PROVEAN
Uncertain
-3.6
D
REVEL
Pathogenic
0.82
Sift
Uncertain
0.013
D
Sift4G
Benign
0.075
T
Polyphen
0.95
P
Vest4
0.84
MVP
0.91
MPC
1.6
ClinPred
0.037
T
GERP RS
5.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.52
gMVP
0.81
Mutation Taster
=10/90
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201870832; hg19: chr2-152727089; COSMIC: COSV99071489; COSMIC: COSV99071489; API